Armodafinil
- CAS No.
- 112111-43-0
- Chemical Name:
- Armodafinil
- Synonyms
- Nuvigil;CRL 40982;CEP 10952;R MODAFINIL; Armodafinil;(-)-Modafinil;Modafinil R-Isomer;Armodafinil CIV (500 mg);ARMODAFINIL DRUG SUBSTANCE;(R)-2-(benzhydrylsulfinyl)acetamide
- CBNumber:
- CB3500844
- Molecular Formula:
- C15H15NO2S
- Molecular Weight:
- 273.35
- MDL Number:
- MFCD09841055
- MOL File:
- 112111-43-0.mol
- MSDS File:
- SDS
| Melting point | 156-1580C |
|---|---|
| Boiling point | 559.1±50.0 °C(Predicted) |
| Density | 1.283 |
| storage temp. | Controlled Substance, -20°C Freezer |
| solubility | DMSO: ≥16mg/mL |
| pka | 14.88±0.40(Predicted) |
| form | powder |
| color | white to tan |
| optical activity | [α]/D -15 to -20° in methanol (C=1) |
| NCI Dictionary of Cancer Terms | armodafinil; Nuvigil |
| FDA UNII | V63XWA605I |
| NCI Drug Dictionary | armodafinil |
| ATC code | N06BA13 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H361d | |||||||||
| Precautionary statements | P202-P264-P270-P280-P301+P312-P308+P313 | |||||||||
| Hazard Codes | Xi | |||||||||
| Risk Statements | 41 | |||||||||
| Safety Statements | 26-39 | |||||||||
| WGK Germany | 3 | |||||||||
| NFPA 704 |
|
Armodafinil price More Price(14)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | SML0039 | Armodafinil ≥98% (HPLC) | 112111-43-0 | 10mg | $143 | 2026-04-30 | Buy |
| Sigma-Aldrich | SML0039 | Armodafinil ≥98% (HPLC) | 112111-43-0 | 50mg | $532 | 2026-04-30 | Buy |
| Cayman Chemical | 29910 | (R)-Modafinil ≥98% | 112111-43-0 | 1mg | $42 | 2026-04-30 | Buy |
| Cayman Chemical | 29910 | (R)-Modafinil ≥98% | 112111-43-0 | 5mg | $115 | 2026-04-30 | Buy |
| Cayman Chemical | 29910 | (R)-Modafinil ≥98% | 112111-43-0 | 10mg | $143 | 2026-04-30 | Buy |
Armodafinil Chemical Properties,Uses,Production
Description
Armodafinil, an α1-adrenoceptor agonist, was launched for the
oral treatment of excessive sleepiness associated with narcolepsy, SWSD, and
obstructive sleep apnea/hypopnea syndrome (OSA). It is the R-enantiomer
of modafinil, which is a previously marketed wake-promoting agent. The key
differentiator for armodafinil is its longer pharmacokinetic half-life as
compared with the S-enantiomer (10-14 hvs.3-4h). At therapeutic
concentrations, armodafinil does not bind to most of the potentially
relevant receptors for sleep/wake regulation (e.g., serotonin, dopamine,
and adenosine receptors) or transporters of neurotransmitters or enzymes
involved in sleep/wake regulation (e.g., serotonin, norepinephrine, and
phosphodiesterase VI transporters). Both armodafinil and modafinil block
dopamine reuptake by binding to the dopamine transporter and increasing
dopamine concentrations in certain regions of the brain. However, dopamine
receptor antagonists (e.g., haloperidol) and dopamine synthesis inhibitors
(e.g., α-methyl-p-tyrosine) do not block modafinil’s action.
In addition to its wake-promoting effects and ability to increase locomotor activity in animals, modafinil produces psychoactive and euphoric effects, alterations in mood, perception, thinking, and feelings typical of other CNS stimulants in humans. Modafinil was also partially discriminated as stimulant-like. However, the potential for abuse and dependency appears to be lower for modafinil than amphetamine-like stimulants.The most common adverse
events associated with armodafinil included headache, nausea, dizziness,
and insomnia.
Chemical Properties
White Solid
Originator
Cephalon (US)
Uses
Used for treatment of excessive sleepiness, a1-adrenoceptor agonist
Uses
Used for treatment of excessive sleepiness, α1-adrenoceptor agonist.
Uses
analeptic
Definition
ChEBI: A 2-[(diphenylmethyl)sulfinyl]acetamide that has R configuration at the sulfur atom. Like its racemate, modafinil, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disord r. Peak concentration in the blood later occurs later following administration than with modafinil, so it is thought that armodafinil may be more effective than modafinil in treating people with excessive daytime sleepiness.
brand name
Nuvigil
Synthesis
Armodafinil can be obtained starting from (+)-2( diphenylmethylsulfinyl)acetic acid via optical resolution using S-(-)-amethylbenzylamine, followed by esterification to the methyl ester and subsequent amidation with ammonium hydroxide. It can also be derived enantioselectively from 2-(diphenylmethylthio)acetamide via asymmetric oxidation with cumene hydroperoxide and titanium isopropoxide-S,Sdiethyl tartrate complex.
